This program details the RESP and PRESERVE scores for predicting survival with the use of V-V ECMO in the ARDS patient.
Joseph has been a practicing clinical perfusionist for 40 years. Joseph is the CEO of Houston Extracorporeal Technologies and is the program director of The New Orleans Conference